Institut De Recherches Internationales Servier (i.r.i.s.)

This study is testing a drug called vorasidenib in teenagers (ages 12 to under 18) who have a specific type of slow-growing brain tumor. The main goals are to see if the drug is safe, what side effects it causes, and how it might affect the teens' normal growth and development du…

This early-stage study aims to understand how a single dose of the drug vorasidenib is processed by the body in people with severe liver impairment compared to people with normal liver function. It will involve 20 participants who will be closely monitored for safety and have the…